DOLBY LABORATORIES, INC. (DLB): what the price requires
At today's price, DOLBY LABORATORIES, INC. (DLB) is priced for -1.2% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/DLB
Headline
| Field | Value |
|---|---|
| Ticker | DLB |
| Company | DOLBY LABORATORIES, INC. |
| Current price | $49.32/sh |
| Composition | Licensing 93% / Products and services 7% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 12.5% |
| Operating margin today | 23.2% |
| Margin compression implied | -10.7pp |
| Implied growth | -1.2% |
| Multiple paid | 12x operating income |
The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.
Solve inputs: computed at a 8.9% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~5.5pp.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | -0.14σ |
| cohort percentile (of 177 peers) | 12 |
| implied end-window share | 0% |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.78x | 5 | expensive |
| Earnings | 1.81x | 5 | expensive |
| Relative | 1.27x | 3 | expensive |
| Growth | 1.17x | 4 | expensive |
Families that justify the price: Growth Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.0%); the inversion above states its own rate.
Per-Model Detail (n=17)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $61.13 | 0.81x | yes | FCF base $0.3B, growth 4% (input: historical growth), terminal g 3.5%, WACC 9.0%, 5yr projection |
| DCF Exit Multiple | Growth | $50.65 | 0.97x | yes | Exit EV/EBITDA: 13.6x / 15.6x / 17.6x (bear / base = today's held flat / bull), 5yr |
| Relative Valuation | Relative | $43.21 | 1.14x | yes | P/E 18x (static sector reference · 2026-04), scenarios: 15.1x / 18.0x / 20.9x (bear / base = reference held flat / bull), EV/EBITDA 12x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | $19.52 | 2.53x | yes | Stage 1: -3% for 5yr, Stage 2: 3.5% perpetual |
| Simple Excess Return | Asset | $27.58 | 1.79x | yes | BV/sh $27.41, ROE (TTM) 9.3%, ke 9.3% |
| Two-Stage Excess Return | Asset | $27.66 | 1.78x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $35.90 | 1.37x | yes | Rev $1.4B, growth 4% (input: historical growth; tapered), Terminal P/S: 2.9x / 3.5x / 4.0x (bear / base = today's held flat / bull, cap 8x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $27.29 | 1.81x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.25B × (1−20%) / WACC 9.0% → EPV (no growth) |
| Residual Income | Asset | $27.67 | 1.78x | yes | BV $27.41 + 5yr PV of (ROE (TTM) 9.3% − Kₑ 9.3%) × BV; BV grows 6.0%/yr |
| Graham Number | Asset | $39.42 | 1.25x | yes | √(22.5 × EPS $2.52 × BVPS $27.41) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $38.90 | 1.27x | yes | EBITDA $0.28B × sector EV/EBITDA 12.0x |
| FCF Yield | Earnings | $38.28 | 1.29x | yes | FCF $301.5M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $23.60 | 2.09x | yes | SBC-adj FCF $0.17B (FCF $0.30B − SBC $0.13B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $5.95 | 8.29x | yes | EPS $2.52 × (8.5 + 2×-2.8%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $12.30 | 4.01x | yes | BV $27.41 × (ROIC 4.1% / WACC 9.0%) |
| P/Sales Sector | Relative | $35.72 | 1.38x | yes | Revenue $1.36B × sector P/S 2.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $27.24 | 1.81x | yes | EPS $2.52 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net cash | $594.7m |
| Net debt / NOPAT (after-tax) | -2.26x (net cash) |
| Net debt / operating income (pre-tax) | -1.80x (net cash) |
| Share count CAGR (buyback) | -1.8% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
Dolby is a licensing business, with about 93% of revenue from royalties, so the assets that matter sit off the balance sheet as patents rather than on it as plant. That makes the asset-based models understate it and puts the weight on the durability of the royalty stream.
At about $52 the price inverts to roughly 1% operating-profit growth a year, an undemanding bar for a company guiding its Atmos, Vision, and imaging patents to grow about 15% and to reach nearly half of licensing revenue.
The balance sheet is pristine: no debt and about $595 million of cash, funding a $0.36 quarterly dividend and a buyback that has retired more than 54 million shares since 2009. The catch is concentration: the whole thesis rests on a handful of audio and video standards holding their position.
Bull Case
Valuing Dolby is a different exercise from valuing most companies, and the difference is the whole bull case. This is an intellectual-property licensor: roughly 93% of revenue is royalties paid by device makers and content platforms to use Dolby's audio and video standards. The economic engine is a portfolio of patents and standards, which means the most valuable assets never appear on the balance sheet. So the asset-based models, which anchor on a $27 book value, structurally understate the business, and the earnings-power frame, which capitalizes current profit without growth, lands near $27 as well. For an IP business the right lens is the size and durability of the royalty base, and on that lens Dolby looks underpriced relative to a price that only requires about 1% operating-profit growth a year.
The royalty base is growing where it matters. Fiscal second-quarter 2026 revenue rose 7% to $396 million, with licensing at $372.2 million, driven by adoption across sports, automotive, mobile, and content platforms. Management guides its key Atmos, Vision, and imaging patents to grow about 15% and to make up nearly half of licensing revenue, and is targeting 15% to 20% annual growth for that portfolio over the next several years. The automotive channel is the clearest new leg: BMW, BYD, Lexus, Hyundai, and NIO have added or expanded Atmos-enabled vehicles, with new agreements signed with Maruti Suzuki, Deepal, and VinFast. In music, over 90% of Billboard's top 100 artists are now creating in Atmos. Each new screen, speaker, and dashboard that ships with Dolby inside is an annuity-like royalty that costs Dolby almost nothing incremental to earn.
The balance sheet and capital return seal the quality argument. Dolby carries no debt and about $595 million of cash, which it deploys into a $0.36 quarterly dividend and a long-running buyback that has retired more than 54 million shares for roughly $3.16 billion since 2009. The filings note that recovery payments from licensees, in the form of back payments and settlements, have become a recurring element of the business (Dolby FY2025 10-K, accession 0001308547-25-000007), a sign that the enforcement machinery behind the royalties is active. Analysts carry a Buy consensus with an average target near $90. The bull thesis is simple: a debt-free, high-margin licensor whose newest standards are compounding mid-teens, priced as if the royalty stream barely grows.
Bear Case
The advantage that is most exposed to erosion is the one the entire thesis rests on: the indispensability of Dolby's standards. A licensing moat lasts only as long as device makers and platforms keep choosing to pay rather than route around. The risk is real enough that Dolby's own filings acknowledge that if it cannot license or develop technologies for parts of its business found to be infringing, it may be forced to limit its offerings and could be unable to compete (Dolby FY2025 10-K, accession 0001308547-25-000007). The flip side is the same dynamic from the licensee's view: free and open codecs, in-house formats from large platforms, and competing immersive-audio standards all chip at the willingness to pay. Once a major platform decides a Dolby standard is optional, the royalty does not shrink gradually; it steps down at renewal.
The second pressure point is the quality of the revenue line itself. Dolby discloses that some licensees underreport royalties, and that recovery payments through back payments and settlements have become a recurring element of revenue, while noting it cannot predict that revenue with certainty (Dolby FY2025 10-K, accession 0001308547-25-000007). Recoveries and recurring true-ups make the headline growth lumpier than it looks, and they depend on continued enforcement against a global base of licensees. The fiscal second quarter showed the tension: revenue grew 7%, but non-GAAP earnings per share were flat at $1.37, so the growth is not yet dropping cleanly to the bottom line, and the third-quarter guide of $0.56 to $0.71 non-GAAP EPS reflects the seasonality and unevenness of a licensing model.
The valuation leaves modest room but not a wide margin. The conservative methods, asset-based and earnings-power, sit in the high $20s, well below the $52 price (June 27, 2026), so the stock is not cheap on what the business earns at zero growth; it requires the royalty base to keep expanding. The implied 1% growth bar is low, but it is a bar that assumes no net erosion, and an IP business with concentrated standards and revenue that includes recurring legal recoveries is exactly the kind of business where the static methods deserve weight. If the Atmos and Vision adoption curve flattens, or a large platform negotiates Dolby down, the price has further to fall than the low implied-growth figure suggests.
Valuation
At about $52 the price inverts to roughly 1% operating-profit growth a year over five years, with implied margin near 14% against today's 18.5%. The solve runs at a 9% cost of capital, and it is moderately sensitive: each percentage point of cost of capital moves the implied growth by roughly 5.7 points. The implied pace sits comfortably within Dolby's own history, so the embedded assumption is undemanding, and the open question is the durability of the royalty base rather than the modest rate.
The model X-ray is shaped by Dolby's licensing economics. The asset-based and earnings-power methods cluster in the high $20s, near a $27 book value, because they cannot value a patent portfolio that earns far more than its accounting carrying value, so they understate an IP business by design. The relative method lands near $43 on an 18-times sector P/E, the EV/EBITDA relative near $39, and the FCF-yield method near $38. The growth methods reach higher: the perpetual-growth DCF near $61 and the exit-multiple DCF near $53, right at the price.
The bet at $52 is therefore that the royalty stream is durable and that Atmos, Vision, and imaging keep compounding, a low hurdle given the guidance, with the real risk being not the rate of growth but whether the standards hold their place.
Catalysts
Fiscal second-quarter 2026 results were the most recent catalyst. Revenue rose 7% to $396 million, with licensing at $372.2 million, while GAAP net income was $95 million, or $0.99 a share, and non-GAAP EPS was flat at $1.37. Dolby guided full-year 2026 revenue to $1.40 billion to $1.45 billion and licensing to $1.295 billion to $1.345 billion, with third-quarter revenue of $295 million to $325 million and non-GAAP EPS of $0.56 to $0.71. Management reiterated that Atmos, Vision, and imaging patents should grow about 15% and approach half of licensing revenue.
The forward catalysts are adoption-driven. Automotive continues to expand, with BMW, BYD, Lexus, Hyundai, and NIO adding Atmos-enabled vehicles and new agreements with Maruti Suzuki, Deepal, and VinFast. New initiatives including Dolby Vision 2 and OptiView are aimed at extending the standards across TVs and mobile. Capital return continues through the $0.36 quarterly dividend and the long-running buyback. Analysts hold a Buy consensus with an average target near $90. The watch items are the trajectory of the key-patent portfolio toward its mid-teens growth target, the pace of automotive and content-platform wins, the cadence of licensee recovery payments, and renewal terms with large platform licensees.
Peer Cohorts (Per Segment, With Filing Citations)
Audio/video technology licensing & products (single reportable segment) (reported)
- IDCC (INTERDIGITAL, INC.)
- (no filing in the citation store)
- RMBS (RAMBUS INC)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.